A research team led by prominent industry critic Dr Pieter Cohen has found that FDA warning letters sent to companies using phenibut in dietary supplements didn’t prevent other firms from continuing to use the illegal ingredient.
The ongoing inaction by the US Food and Drug Administration over CBD (cannabidiol) in foods and dietary supplements is having a negative impact on trademark laws, says an industry lawyer.
A new Congressional report on dietary supplements reflects recent priorities with a heavy emphasis on a proposed mandatory product registry and the CBD question.
New research has warned about the importance of expert guidance and biochemical monitoring for sports nutrition users, as it finds a link between supplement consumption and alterations in liver and kidney function.
The American Herbal Products Association has announced a focus on immunity for its annual Congress event that traditionally is scheduled to follow on the Supply Side West trade show in Las Vegas.
US federal regulatory agencies have issued warnings on the availability of delta-8 THC, saying reports of almost 150 recent emergency room visits have mentioned the substance.
An FDA warning letter has been issued for a an under the radar topical herbal product known as Black Salve that continues to appear on the market even after the Agency issued a consumer warning calling the product “life threatening.”
The US Food and Drug Administration has announced 12 winners of a challenge aimed at increasing supply chain transparency and traceability for ingredients and whole foods.
The California Legislature has passed a bipartisan bill to establish rules for the production and marketing of CBD/hemp products. Proponents expect Gov. Gavin Newsom to sign the bill into law before the Oct. 10 deadline.
A bill has been introduced into the US House of Representatives that would allow Health Savings Account (HSA) funds to be used to pay for dietary supplements. The bill mirrors most of the provisions of a bill already in the Senate.
